Superworth

Outset Medical profit margin OM

Gross, operating and net profit as a share of revenue over the last twelve months, from 2025.

Net margin, 12 months
−63.1%
Operating margin, 12 months
−56.1%
Net margin on a year earlier
+19.0 pts
Peer median
6.8%

Over the twelve months to Jun 30, 2026, Outset Medical kept −63.1% of its revenue as net profit, with an operating margin of −56.1% and a gross margin of 41.8%.

The median for 10 healthcare stocks of a similar size is 6.8%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−68.3%−55.8%39.1%
FY2024n/a−99.7%33.9%
FY2023n/an/a22.2%
FY2022n/an/a15.5%
FY2021n/an/a7.4%
FY2020n/an/a−26.1%
FY2019n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−63.1%+19.0 pts−56.1%
Q1 FY26−63.7%+35.1 pts−57.2%
Q4 FY25−68.3%n/a−55.8%
Q3 FY25−73.1%n/a−59.1%
Q2 FY25−82.1%n/a−66.2%
Q1 FY25−98.7%n/a−80.6%
Q4 FY24n/an/a−99.7%
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Healthcare nearest Outset Medical's size, closest first, today.

CompanyProfit margin
OMOutset Medical−63.1%
LFVNLifevantage2.8%
SPROSpero Therapeutics15.7%
ICCCImmucell2.6%
KEQUKewaunee Scientific3.0%
APTAlpha Pro Tech6.8%
ATNMActinium Pharmaceuticalsn/m
NEPHNephros8.4%
PDEXPro DEX17.6%
PLXProtalix BioTherapeutics23.5%
NATRNatures Sunshine Products3.7%
Peer median6.8%

Where Outset Medical ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Outset Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.